Mail

NEO - NeoGenomics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

32.66

+0.61 (+1.90%)

As of 10:30AM EST. Market open.

Stock chart is not supported by your current browser

Previous Close	32.05
Open	32.04
Bid	32.77 x 800
Ask	32.79 x 1100
Day's Range	32.01 - 32.84
52 Week Range	15.56 - 33.21
Volume	144,598
Avg. Volume	732,267

Market Cap	3.41B
Beta (5Y Monthly)	1.05
PE Ratio (TTM)	1,484.55
EPS (TTM)	0.02
Earnings Date	Feb 16, 2020 - Feb 20, 2020
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	28.33

All

News

Press Releases

Investor's Business Daily Video
NEO Breaks Out
Cancer testing firm NeoGenomics broke out Thursday from a flat base, a couple of days after reporting strong earnings. NEO is stock of the day. Many cancer-testing firms are doing well.STOCK MARKET TODAY is sponsored by Interactive Brokers. To open an account, go to ibkr.com/whyib
Business Wire
2020 OUTLOOK AND INSIGHTS: Investment Trends and Themes to be Highlighted at the Emerald Groundhog Day Investment Forum
2020 Market Outlook and Insights for Investors: Join us for the 27th annual Emerald Groundhog Day Investment Forum - February 6th in Philadelphia.
Benzinga
The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 13.) Arvinas Inc (NASDAQ: ARVN ) Baxter International ...
ACCESSWIRE
NeoGenomics Acquires Oncology Division from Human Longevity for $37 Million
Significantly Enhances Next Generation Sequencing Capabilities for Pharmaceutical Customers FT. MYERS, FL / ACCESSWIRE / January 10, 2020 / NeoGenomics, Inc. (NASDAQ:NEO) , a leading provider of cancer-focused ...
Insider Monkey
Did Hedge Funds Drop The Ball On NeoGenomics, Inc. (NEO) ?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]
ACCESSWIRE
NeoGenomics To Participate In Fireside Chat At Stephens 21st Annual Investment Conference
FT. MYERS, FL / ACCESSWIRE / November 6, 2019 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, today announced that Doug VanOort, Chairman and Chief Executive ...
Simply Wall St.
Have Insiders Sold NeoGenomics, Inc. (NASDAQ:NEO) Shares Recently?
Anyone interested in NeoGenomics, Inc. (NASDAQ:NEO) should probably be aware that the President of Clinical Services...
Thomson Reuters StreetEvents
Edited Transcript of NEO earnings conference call or presentation 29-Oct-19 12:30pm GMT
Q3 2019 Neogenomics Inc Earnings Call
Zacks
Healthcare ETF (IHF) Tops in October: 5 Best Stocks
Inside the best performing stocks of the top ETF of October.
Zacks
NeoGenomics (NEO) Tops Q3 Earnings and Revenue Estimates
NeoGenomics (NEO) delivered earnings and revenue surprises of 16.67% and 5.50%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
ACCESSWIRE
NeoGenomics Reports 51% Revenue Growth to $105 Million in the Third Quarter
T hird-Quarter Highlights: Consolidated revenue increased 51% to $104.7 million Clinical Services revenue increased 56% to $92.6 million Pharma Services revenue increased 26% to $12.1 million Pharma Services ...
Insider Monkey
Is NeoGenomics, Inc. (NEO) Going To Burn These Hedge Funds ?
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms' equity portfolios as of June 28. The results of that effort will be put on display in this article, as […]
Simply Wall St.
Is Now An Opportune Moment To Examine NeoGenomics, Inc. (NASDAQ:NEO)?
NeoGenomics, Inc. (NASDAQ:NEO), which is in the life sciences business, and is based in United States, saw significant...
ACCESSWIRE
NeoGenomics Schedules its Third Quarter Earnings Release for October 29, 2019
FT. MYERS, FL / ACCESSWIRE / October 1, 2019 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its Third quarter ...
ACCESSWIRE
NeoGenomics To Present At 2019 Cantor Global Healthcare Conference
FT. MYERS, FL / ACCESSWIRE / September 25, 2019 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, today announced that Bill Bonello, Chief Strategy and Corporate ...
Simply Wall St.
Introducing NeoGenomics (NASDAQ:NEO), The Stock That Zoomed 298% In The Last Five Years
NeoGenomics, Inc. (NASDAQ:NEO) shareholders have seen the share price descend 14% over the month. But in stark...
TheStreet.com
NeoGenomics Has Attractive Charts and Should Continue Its Uptrend
During Friday's Lightning Round of Mad Money one caller asked about the Fort Meyers, FL headquartered NeoGenomics : "I won't say no to anyone working to cure cancer," replied Jim Cramer. NeoGenomics is a clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. In this daily bar chart of NEO, below, we can see that prices more than doubled this calendar year.
ACCESSWIRE
NeoGenomics to Participate in Two Upcoming September Institutional Investor Conferences
The Morgan Stanley conference presentation will be webcast live and accessible online via the investors section of the Company’s website, www.neogenomics.com. NeoGenomics, Inc. specializes in cancer genetic testing and information services.
Simply Wall St.
We Think NeoGenomics (NASDAQ:NEO) Can Manage Its Debt With Ease
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
ACCESSWIRE
Neo Performance Materials, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 12, 2019 / Neo Performance Materials, Inc. (NASDAQ: NEO ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August 12, 2019 ...
ACCESSWIRE
NeoGenomics Announces Leadership Transition and Reiterates Recently Increased 2019 Financial Guidance
FT. MYERS, FL / ACCESSWIRE / August 8, 2019 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, this morning filed an 8-K with the Securities and Exchange Commission ...
Motley Fool
Here's Why Genetic Testing Stocks Rose as Much as 25.4% in July
It was a great month to be a genetic testing company.
Thomson Reuters StreetEvents
Edited Transcript of NEO earnings conference call or presentation 30-Jul-19 12:30pm GMT
Q2 2019 Neogenomics Inc Earnings Call
Investor's Business Daily
IBD Stock Of The Day With 93% Gain This Year Breaks Out Again
NeoGenomics stock is the IBD Stock Of The Day as the cancer-testing outlet breaks out on a never-higher relative strength line. Earlier this week, NeoGenomics posted a quarterly beat.
ACCESSWIRE
NeoGenomics Announces Grand Opening of New Pharma Services Laboratory in Singapore
FORT MYERS, FL and WILMINGTON, NC / ACCESSWIRE / July 31, 2019 / NeoGenomics, Inc. (NEO), a leading provider of cancer-focused genetics testing services, and Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization (CRO), announced the grand opening of a NeoGenomics oncology-focused clinical trials testing lab in the same building as the PPD® Laboratories central lab in Singapore. NeoGenomics’ Pharmaceutical Services Division has established a track record of rapid growth and is building a global network for clinical trials.